NASDAQ:SBPH - Nasdaq -
1.21
0 (0%)
The current stock price of SBPH is 1.21 null. In the past month the price decreased by -4.72%. In the past year, price decreased by -59.8%.
Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including hepatitis B virus. Spring Bank Pharmaceuticals, Inc. is based in Hopkinton, United States.
Spring Bank Ph CS
35 PARKWOOD DRIVE SUITE 210
HOPKINTON MA 01748
CEO: Martin Driscoll
Phone: 508-473-5993
The current stock price of SBPH is 1.21 null.
The exchange symbol of Spring Bank Ph CS is SBPH and it is listed on the Nasdaq exchange.
SBPH stock is listed on the Nasdaq exchange.
Spring Bank Ph CS (SBPH) has a market capitalization of 20.89M null. This makes SBPH a Nano Cap stock.
Spring Bank Ph CS (SBPH) has a support level at 1.05 and a resistance level at 1.3. Check the full technical report for a detailed analysis of SBPH support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SBPH does not pay a dividend.
Spring Bank Ph CS (SBPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.74).
ChartMill assigns a fundamental rating of 2 / 10 to SBPH. SBPH has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months SBPH reported a non-GAAP Earnings per Share(EPS) of -1.74. The EPS decreased by -8.07% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -100.99% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 60% to SBPH. The Buy consensus is the average rating of analysts ratings from 1 analysts.